EMN EASTMAN CHEMICAL CO
Plastic Materials, Synth Resins & Nonvulcan Elastomers · NYSE · SEC CIK 915389 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.3%
TTM net income YoY-10.3%
TTM EPS YoY-12.4%
Revenue 3-yr CAGR-1.2%
Net income 3-yr CAGR3.4%
Margins
Gross margin20.6%
Operating margin—
Net margin7.2%
FCF margin5.2%
EBITDA margin—
Returns
ROE10.7%
ROA4.3%
ROIC (approx.)—
Asset turnover0.59x
Leverage & solvency
Liabilities / assets59.0%
Debt / equity0.83x
Current ratio1.57x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.36x
Accruals ratio-1.5%
Payout ratio59.0%
Capex / revenue4.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $8.75B | $9.38B |
| Cost of revenue | $6.91B | $7.09B |
| Gross profit | $1.84B | $2.29B |
| R&D expense | $255.00M | $250.00M |
| SG&A expense | $658.00M | $736.00M |
| Pretax income | $568.00M | $1.08B |
| Income tax | $93.00M | $170.00M |
| Net income | $474.00M | $905.00M |
| EPS (basic) | 4.14 | 7.75 |
| EPS (diluted) | 4.10 | 7.67 |
| Dividends declared per share | 3.33 | 3.26 |
| Weighted avg. shares (diluted) | 115.60M | 117.90M |
| Banking | ||
| Net interest income | -$208.00M | -$200.00M |
| Balance sheet | ||
| Cash & equivalents | $566.00M | $837.00M |
| Receivables | $737.00M | $791.00M |
| Inventory | $1.98B | $1.99B |
| Current assets | $3.65B | $4.10B |
| PP&E, net | $5.73B | $5.62B |
| Goodwill | $3.67B | $3.63B |
| Intangibles | $970.00M | $1.03B |
| Total assets | $14.86B | $15.21B |
| Current liabilities | $2.65B | $2.71B |
| Short-term debt | $586.00M | $450.00M |
| Long-term debt | $4.20B | $4.57B |
| Total debt | $4.79B | $5.02B |
| Total liabilities | $8.82B | $9.36B |
| Shareholders' equity | $5.96B | $5.78B |
| Net debt | $4.22B | $4.18B |
| Shares outstanding | 223.94M | 223.59M |
| Cash flow statement | ||
| Operating cash flow | $970.00M | $1.29B |
| Capital expenditure | $546.00M | $599.00M |
| Free cash flow | $424.00M | $688.00M |
| Investing cash flow | -$462.00M | -$534.00M |
| Financing cash flow | -$797.00M | -$454.00M |
| Depreciation & amortization | $513.00M | $509.00M |
| Stock-based compensation | $48.00M | $63.00M |
| Dividends paid | $381.00M | $379.00M |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.